Ardelyx | ARDX - Current Assets

Stock Price
5.95
Daily Change
-0.01 -0.17%
Monthly
5.50%
Yearly
13.12%
Q2 Forecast
5.82

Ardelyx reported $382.32M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
Amgen USD 29.06B 1.17B Dec/2025
Ardelyx USD 382.32M 14.33M Dec/2025
aTyr Pharma USD 245.8M 152.79M Dec/2025
Corcept Therapeutics USD 485.46M 55.67M Dec/2025
Curis USD 6.92M 7.5M Dec/2025
Sanofi EUR 30.95B 8.99B Dec/2025
TG Therapeutics USD 630.76M 31M Dec/2025
United Therapeutics USD 3.7B 208.5M Dec/2025
Xoma USD 110.71M 5.78M Sep/2025